Evidence map›Paper›PMID 30442927›Full record

ArticleCell death & disease2018

c-Jun N-terminal kinases differentially regulate TNF- and TLRs-mediated necroptosis through their kinase-dependent and -independent activities.

Mengtao Cao, Fei Chen, Ni Xie, Meng-Yao Cao, Pengfei Chen, Qi Lou, Yanli Zhao, Chen He, Shuyuan Zhang, Xinyang Song and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Exploring the Role ofToxins · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Mengtao CaoInstitute of Transformation Medicine, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen University School of Medicine, 518300, Shenzhen, China. mtcao@sibs.ac.cn.
Fei ChenInstitute of Transformation Medicine, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen University School of Medicine, 518300, Shenzhen, China.
Ni XieInstitute of Transformation Medicine, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen University School of Medicine, 518300, Shenzhen, China.
Meng-Yao CaoDepartment of Radiology, The People's Hospital of Tongliang District, 402560, Chongqing, China.
Pengfei ChenInstitute of Transformation Medicine, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen University School of Medicine, 518300, Shenzhen, China.
Qi LouInstitute of Transformation Medicine, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen University School of Medicine, 518300, Shenzhen, China.
Yanli ZhaoInstitute of Transformation Medicine, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen University School of Medicine, 518300, Shenzhen, China.
Chen HeDepartment of Ophthalmology, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, 518035, Shenzhen, Guangdong, China.
Shuyuan ZhangDepartment of Nephrology, Shenzhen Longhua District Central Hospital, Guangdong Medical University Affiliated Longhua District Central Hospital, 518300, Shenzhen, China.
Xinyang SongDivision of Immunology, Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, 02115, USA.
Yu SunThe Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, University of Chinese Academy of Science, 200031, Shanghai, China.ORCID http://orcid.org/0000-0001-7121-9112
Weimin ZhuDepartment of Sports Medicine, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, 518035, Shenzhen, Guangdong, China.
Lisha MouInstitute of Transformation Medicine, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen University School of Medicine, 518300, Shenzhen, China.
Shaodong LuanDepartment of Nephrology, Shenzhen Longhua District Central Hospital, Guangdong Medical University Affiliated Longhua District Central Hospital, 518300, Shenzhen, China.
Hanchao GaoInstitute of Transformation Medicine, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen University School of Medicine, 518300, Shenzhen, China. hcgao@foxmail.com.
Shenzhen Second People's Hospital · CNChinese Academy of Sciences · CNGuangdong Medical College · CNShanghai Institutes for Biological Sciences · CNHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor necrosis factor (TNF) and Toll-like receptor (TLR)3/TLR4 activation trigger necroptotic cell death through downstream signaling complex containing receptor-interacting protein kinase 1 (RIPK1), RIPK3, and pseudokinase mixed lineage kinase-domain-like (MLKL). However, the regulation of necroptotic signaling pathway is far less investigated. Here we showed that c-Jun N-terminal kinases (JNK1 and JNK2) displayed kinase-dependent and -independent functions in regulating TNF- and TLRs-mediated necroptosis. We found that RIPK1 and RIPK3 promoted cell-death-independent JNK activation in macrophages, which contributed to pro-inflammatory cytokines production. Meanwhile, blocking the kinase activity of JNK dramatically reduced TNF and TLRs-induced necroptotic cell death. Consistently, inhibition of JNK activity protected mice from TNF-induced death and Staphylococcus aureus-mediated lung damage. However, depletion of JNK protein using siRNA sensitized macrophages to necroptosis that was triggered by LPS or poly I:C but still inhibited TNF-induced necroptosis. Mechanistic studies revealed that RIPK1 recruited JNK to the necrosome complex and their kinase activity was required for necrosome formation and the phosphorylation of MLKL in TNF- and TLRs-induced necroptosis. Loss of JNK protein consistently suppressed the phosphorylation of MLKL and necrosome formation in TNF-triggered necroptosis, but differentially promoted the phosphorylation of MLKL and necrosome formation in poly I:C-triggered necroptosis by promoting the oligomeration of TRIF. In conclusion, our findings define a differential role for JNK in regulating TNF- and TLRs-mediated necroptosis by their kinase or scaffolding activities.

Indexed as

Adaptor Proteins, Vesicular TransportAnimalsApoptosisCell DeathHumansInflammationMiceMitogen-Activated Protein Kinase 8Mitogen-Activated Protein Kinase 9PhosphorylationPoly I-CProtein KinasesRAW 264.7 CellsReceptor-Interacting Protein Serine-Threonine KinasesSignal TransductionStaphylococcus aureusAdaptor Proteins, Vesicular TransportMitogen-Activated Protein Kinase 8Mitogen-Activated Protein Kinase 9MLKL protein, mousePoly I-CProtein KinasesReceptor-Interacting Protein Serine-Threonine KinasesRipk1 protein, mouseRipk3 protein, mouseTicam1 protein, mouseToll-Like Receptor 3Toll-Like Receptor 4Tumor Necrosis Factor-alpha

Identifiers

PMID30442927
PMCPMC6238001
OpenAlexW2901715240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.